# APTOF (Aptose Biosciences Inc.) - SEC EDGAR Financial Statements

> Aptose Biosciences Inc. reported $0 in revenue and a net loss of $27.56M for the trailing twelve months ended March 31, 2026.

- Canonical: https://convexityos.com/fundamentals/APTOF
- Markdown: https://convexityos.com/fundamentals/APTOF.md
- SEC CIK: 0000882361
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882361&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Mar 31, 2026 |
| Operating Income | TTM | -- | Operating profit |
| Net Income | TTM | -$27.56M | GAAP bottom line |
| Diluted EPS | TTM | -$10.80 | Split-adjusted |
| Free Cash Flow | TTM | -$21.99M | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $1.02M | Total debt: $80K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | -- | -- |
| Research & Development | $11.34M | $15.10M | $33.27M | $24.53M | $45.98M | $29.29M | $16.84M | $18.73M | $6.27M | $7.83M |
| Total Operating Expenses | $24.72M | $26.26M | $52.36M | $42.60M | $65.45M | $55.77M | $26.86M | $29.11M | $11.83M | $14.27M |
| Interest Income | $105K | $357K | $1.15M | $788K | $94K | $522K | $574K | $283K | $68K | $79K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | $46K |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$25.47M | -$25.43M | -$51.21M | -$41.82M | -$65.35M | -$55.24M | -$26.28M | -$28.87M | -$11.64M | -$14.24M |
| Basic EPS | -$10.41 | -$36.38 | -$227.43 | -$204.20 | -$328.83 | -$301.80 | -$234.23 | -$387.39 | -$234.23 | -- |
| **Diluted EPS** | -$10.41 | -$36.38 | -$227.43 | -$204.20 | -$328.83 | -$301.80 | -$234.23 | -$387.39 | -$234.23 | -- |
| Basic Shares Outstanding | 2.4M | 699.0K | 225.2K | 204.8K | 198 | 181.7K | 111.4K | 74.1K | 49.5K | 28.3K |
| Diluted Shares Outstanding | 2.4M | 699.0K | 225.2K | 204.8K | 198 | 181.7K | 111.4K | 74.1K | 49.5K | 28.3K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $3.62M | $3.47M | $2.21M | $3.30M | $2.36M | -$457K | $4.70M | $4.41M |
| Total Operating Expenses | $7.18M | $7.43M | $4.91M | $6.92M | $5.46M | $2.19M | $6.96M | $7.34M |
| Interest Income | -- | -- | -- | -- | -- | $131K | $12K | $93K |
| **Net Income** | -$7.63M | -$7.76M | -$5.12M | -$7.04M | -$5.54M | -$1.58M | -$6.95M | -$7.25M |
| Basic EPS | -$2.99 | -- | -$2.01 | -$2.76 | -$2.61 | -- | -$11.33 | -$12.99 |
| **Diluted EPS** | -$2.99 | -- | -$2.01 | -$2.76 | -$2.61 | -- | -$11.33 | -$12.99 |
| Basic Shares Outstanding | 2.6M | -- | 2.6M | 2.6M | 2.1M | -- | 613.6K | 558.5K |
| Diluted Shares Outstanding | 2.6M | -- | 2.6M | 2.6M | 2.1M | -- | 613.6K | 558.5K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $935K | $6.15M | $9.25M | $36.97M | $39.11M | $117.4M | $79.84M | $15.30M | $10.63M | $7.94M |
| Short-Term Investments | -- | -- | -- | $9.99M | $40.01M | $5.00M | $17.76M | $440K | $798K | -- |
| **Cash & Short-Term Investments** | $4.10M | $6.70M | $9.30M | $47.00M | $79.13M | $122.4M | $97.60M | $15.74M | $11.43M | $7.94M |
| Other Current Assets | $141K | $570K | $600K | $257K | $133K | $129K | $141K | $101K | $74K | -- |
| **Total Current Assets** | $6.45M | $9.53M | $11.89M | $49.52M | $81.74M | $125.1M | $98.77M | $16.49M | $11.82M | $8.43M |
| Property, Plant & Equipment, Net | $4.0K | $26K | $152K | $211K | $323K | $261K | $334K | $384K | $142K | $213K |
| Other Non-Current Assets | $3.39M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $3.57M | $597K | $1.09M | $1.51M | $788K | $1.19M | $1.71M | $384K | $142K | $213K |
| **Total Assets** | $10.01M | $10.13M | $12.99M | $51.03M | $82.53M | $126.3M | $100.5M | $16.87M | $11.97M | $8.65M |
| Accounts Payable | $2.91M | $1.26M | $3.49M | $3.34M | $1.70M | $2.17M | $1.96M | $1.31M | $589K | $1.32M |
| **Total Current Liabilities** | $9.31M | $4.46M | $15.27M | $12.28M | $8.17M | $6.81M | $5.54M | $2.79M | $1.76M | $1.32M |
| **Total Non-Current Liabilities** | $27.87M | $10.21M | $621K | $1.00M | $115K | $535K | $1.01M | $0 | $0 | $0 |
| **Total Liabilities** | $37.18M | $14.67M | $15.89M | $13.29M | $8.29M | $7.35M | $6.55M | $2.79M | $1.76M | $1.32M |
| **Total Debt (incl. Leases)** | $193K | $621K | $1.01M | $1.30M | $574K | $1.07M | $1.53M | -- | -- | -- |
| Common Stock | $459.8M | $457.4M | $444.8M | $437.5M | $437.4M | $429.5M | $365.5M | $261.1M | $231.9M | $218.0M |
| Retained Earnings | -$566.4M | -$541.0M | -$515.5M | -$464.3M | -$422.5M | -$357.2M | -$301.9M | -$275.6M | -$246.8M | -$235.1M |
| Accumulated Other Comp. Income | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.30M | -$4.32M | -$4.32M | -- |
| **Total Stockholders' Equity** | -$27.17M | -$4.54M | -$2.90M | $37.74M | $74.24M | $118.9M | $93.93M | $14.08M | $10.20M | $7.33M |
| Total Equity | -$27.17M | -$4.54M | -$2.90M | $37.74M | $74.24M | $118.9M | $93.93M | $14.08M | $10.20M | $7.33M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.02M | $935K | $613K | $553K | $4.74M | $6.15M | $7.96M | $8.33M |
| **Cash & Short-Term Investments** | $4.10M | $4.10M | $1.60M | $1.30M | $4.70M | $6.70M | $8.00M | $8.30M |
| Other Current Assets | $205K | $141K | $127K | $116K | $274K | $570K | $1.36M | $593K |
| **Total Current Assets** | $6.16M | $6.45M | $3.78M | $3.27M | $6.97M | $9.53M | $10.23M | $10.16M |
| Property, Plant & Equipment, Net | $2.0K | $4.0K | $8.0K | $19K | $23K | $26K | $30K | $34K |
| Other Non-Current Assets | $4.50M | $3.39M | $2.28M | $1.92M | -- | $0 | -- | -- |
| **Total Non-Current Assets** | $4.57M | $3.57M | $2.56M | $2.32M | $498K | $597K | $694K | $790K |
| **Total Assets** | $10.72M | $10.01M | $6.34M | $5.59M | $7.47M | $10.13M | $10.93M | $10.95M |
| Accounts Payable | $3.81M | $2.91M | $1.46M | $2.88M | $2.39M | $1.26M | $1.83M | $7.11M |
| **Total Current Liabilities** | $11.24M | $9.31M | $7.08M | $9.00M | $6.32M | $4.46M | $9.76M | $12.71M |
| **Total Non-Current Liabilities** | $34.16M | $27.87M | $18.71M | $10.96M | $8.54M | $10.21M | $10.30M | $414K |
| **Total Liabilities** | $45.40M | $37.18M | $25.79M | $19.96M | $14.86M | $14.67M | $20.06M | $13.12M |
| **Total Debt (incl. Leases)** | $80K | $193K | $305K | $413K | $521K | $621K | $721K | $818K |
| Common Stock | $459.8M | $459.8M | $459.8M | $459.8M | $459.8M | $457.4M | $452.3M | $452.3M |
| Retained Earnings | -$574.1M | -$566.4M | -$558.7M | -$553.6M | -$546.5M | -$541.0M | -$539.4M | -$532.4M |
| Accumulated Other Comp. Income | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.32M | -$4.32M |
| **Total Stockholders' Equity** | -$34.67M | -$27.17M | -$19.45M | -$14.37M | -$7.39M | -$4.54M | -$9.13M | -$2.18M |
| Total Equity | -$34.67M | -$27.17M | -$19.45M | -$14.37M | -$7.39M | -$4.54M | -$9.13M | -$2.18M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$25.47M | -$25.43M | -$51.21M | -$41.82M | -$65.35M | -$55.24M | -$26.28M | -$28.87M | -$11.64M | -$14.24M |
| Depreciation & Amortization | $22K | $32K | $88K | $120K | $150K | $152K | $152K | $87K | $84K | $116K |
| Stock-Based Compensation | $477K | $1.06M | $3.65M | $5.21M | $12.95M | $21.44M | $2.30M | $4.28M | $817K | $1.71M |
| Change in Payables | -- | -- | -- | $4.63M | -$472K | $211K | $645K | $726K | $589K | -- |
| **Operating Cash Flow** | -$21.99M | -$35.98M | -$44.59M | -$32.32M | -$43.30M | -$33.89M | -$21.56M | -$23.21M | -$10.22M | -$12.39M |
| Capital Expenditure | $0 | -$5.0K | -$29K | -$24K | -$212K | -$79K | -$102K | -$329K | -$13K | -$3.0K |
| **Free Cash Flow** | -$21.99M | -$35.98M | -$44.62M | -$32.35M | -$43.52M | -$33.97M | -$21.66M | -$23.54M | -$10.24M | -$12.39M |
| Sales & Maturities of Investments | -- | $0 | $9.99M | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $0 | $18K | $9.96M | $30.07M | -$35.21M | $12.63M | -$17.37M | $12K | -$811K | $6.48M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | $13.39M | $5.73M |
| **Financing Cash Flow** | $19.38M | $33.41M | $6.91M | $116K | $226K | $58.81M | $103.4M | $27.87M | $13.72M | $5.73M |
| **Net Change in Cash** | -$2.61M | -$2.54M | -$27.72M | -$2.14M | -$78.28M | $37.55M | $64.54M | $4.67M | $2.69M | -$371K |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.63M | -$7.76M | -$5.12M | -$7.04M | -$5.54M | -$1.58M | -$6.95M | -$7.25M |
| Depreciation & Amortization | $2.0K | $4.0K | $11K | $4.0K | $3.0K | $4.0K | $4.0K | $8.0K |
| Stock-Based Compensation | $129K | $42K | $44K | $65K | $326K | $57K | -$13K | $207K |
| Change in Payables | $899K | -- | -- | -- | $1.13M | -- | -- | -- |
| **Operating Cash Flow** | -$5.84M | -$5.84M | -$7.41M | -$5.94M | -$2.79M | -$8.06M | -$10.38M | -$5.78M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.01M |
| **Financing Cash Flow** | $5.85M | $8.30M | $7.75M | $2.50M | $829K | $6.80M | $10.01M | $4.75M |
| **Net Change in Cash** | $9.0K | $2.46M | $339K | -$3.44M | -$1.96M | -$1.25M | -$368K | $984K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -110.8% | -88.0% | -46.5% | -28.0% | -205.0% | -114.1% | -194.3% |
| Return on Assets (ROA) | -254.4% | -251.1% | -394.2% | -82.0% | -79.2% | -43.7% | -26.2% | -171.1% | -97.3% | -164.7% |
| Current Ratio | 0.69x | 2.14x | 0.78x | 4.03x | 10.00x | 18.36x | 17.83x | 5.91x | 6.70x | 6.40x |
| Quick Ratio | 0.44x | 1.50x | 0.61x | 3.83x | 9.68x | 17.97x | 17.62x | 5.64x | 6.48x | 6.02x |
| Debt to Equity | -- | -- | -- | 0.03x | 0.01x | 0.01x | 0.02x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -257.0% | -254.4% | -304.3% | -377.8% | -285.7% | -251.1% | -327.6% | -368.0% |
| Current Ratio | 0.55x | 0.69x | 0.53x | 0.36x | 1.10x | 2.14x | 1.05x | 0.80x |
| Quick Ratio | 0.36x | 0.44x | 0.23x | 0.14x | 0.74x | 1.50x | 0.82x | 0.65x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
